Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q1 Loss of 1c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $156.59 +2.10%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $10.84 million.
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CrowdStrike shares jump on earnings beat, raised outlook
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Raymond James Starts Kearny Financial (KRNY) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
